Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society
Lymphatic Research and Biology · 01.10.2022 · 20 (5) · 539-547
DOI: 10.1089/lrb.2021.0032 ↗Kurz gefasst
Leitlinie in der Zeitschrift Lymphatic Research and Biology, online erschienen am 20.10.2022. Verfasst von Kaoru Kitamura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Corporation, Department of Breast Surgery, Fukuoka, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphedema. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Themen: Evidenzbasierte Pflege
Abstract (Originalsprache)
Background
Secondary lymphedema mostly occurs as an aftereffect of cancer treatment, and it is estimated that 100,000–150,000 patients are affected in Japan. An estimated 3500 patients, develop lymphedema of the lower and upper extremities each year secondary to uterine and breast cancer treatment. Medical reimbursement was first instituted in April 2008 by the Ministry of Health, Labour and Welfare in Japan. Since 2008, we have developed guidelines regarding treatment options for patients with lymphedema based on scientific evidence. This is the third edition of the guidelines established by the Japanese Lymphedema Society (JLES), published in 2018. The JLES Practice Guideline-Making Committee (PGMC) developed 21 clinical questions (CQs). Methods and Results: A review of these 15 CQs was performed in accordance with the methodology for establishing clinical guidelines. The 15 recommendations for each of these CQs were developed and discussed until consensus by the PGMC was reached. Moreover, outside members who had no involvement in these guidelines evaluated the contents using the Appraisal of Guidelines for Research and Evaluation (AGREE) II reporting checklist.
Conclusion
These guidelines have been produced for the adequate management of lymphedema by doctors and other medical staff on the lymphedema management team of medical institutes, including nurses, physical technicians, and occupational therapists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Corporation, Department of Breast Surgery, Fukuoka, Japan.
- Department of Emergency and Palliative Medicine, Saitama Medical University, Moroyama, Japan.
- Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.
- Department of Breast Surgical Oncology, Osaka City General Hospital, Osaka, Japan.
- Cancer Screening Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto, Japan.
- Department of Surgery, Seiko Hospital, Neyagawa, Japan.
Zitieren
APA
Kitamura, K., Iwase, S., Komoike, Y., Ogawa, Y., Utsugi, K., Yamamoto, D., & Odagiri, H. (2022). Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society. Lymphatic Research and Biology, 20(5), 539-547. https://doi.org/10.1089/lrb.2021.0032
Vancouver
Kitamura K, Iwase S, Komoike Y, Ogawa Y, Utsugi K, Yamamoto D, et al. Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society. Lymphatic Research and Biology. 2022;20(5):539-547. doi:10.1089/lrb.2021.0032
BibTeX
@article{Kitamura2022,
author = {Kitamura, Kaoru and Iwase, Satoru and Komoike, Yoshifumi and Ogawa, Yoshinari and Utsugi, Kuniko and Yamamoto, Daigo and Odagiri, Hiroki},
title = {Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society},
journal = {Lymphatic Research and Biology},
year = {2022},
volume = {20},
number = {5},
pages = {539--547},
doi = {10.1089/lrb.2021.0032}
}
EUVIMED